Product Details:
| Minimum Order Quantity | 5 Vial |
| Strength | 400 mg |
| Volume | 16 ml |
| Pharmaceutical Form | Injectable Solution |
| Brand | Cizumab 400 |
| Packaging Type | Vial |
| Storage Temperature | 2-8 degree c |
| Storage | 2-8"C |
| Dosage Form | 100mg & 400mg |
| Packaging | 400MG/16ML |
| Manufacturer | Hetero HealthCare |
| Shelf Life | 36 months |
| Product Type | Biosimilar |
| Active Ingredient | Bevacizumab |
| Country of Origin | Made in India |
Additional Information:
Product Details:
| Minimum Order Quantity | 3 Vial |
| Strength | 400 mg |
| Volume | 16 ml |
| Pharmaceutical Form | Solution for Infusion |
| Brand | Reliance Life Sciences |
| Packaging Type | Vial |
| Storage Temperature | 2-8 degree c |
| Storage | 2-8"C |
| Dosage Form | 100mg |
| Packaging | 400MG/16ML |
| Manufacturer | Reliance Life Sciences |
| Shelf Life | 36 months |
| Product Type | Biosimilar |
| Active Ingredient | Bevacizumab |
| Country of Origin | Made in India |
Bevacirel 400mg Injection is indicated along with conventional chemotherapy to improve metastatic breast cancer, kidney cancer, lung cancer, colon and rectum cancer. It is a humanized monoclonal antibody that blocks vascular endothelial growth factor A and angiogenesis. Vascular endothelial growth factor (VEGF) interacts with its receptor to generate angiogenesis, which ultimately facilitates the growth and spread of cancer. This medicine acts against the overexpression of these receptors that is common in several types of cancer.
Additional Information: